Page last updated: 2024-09-05

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Breast Cancer

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acton, EM; Brown, BW; Ehsan, MN; Friend, NF; Hacker, MP; Harker, WG; Newman, RA; Sikic, BI1

Other Studies

1 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Breast Cancer

ArticleYear
Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog.
    Science (New York, N.Y.), 1985, Jun-28, Volume: 228, Issue:4707

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart; Humans; Isoenzymes; L-Lactate Dehydrogenase; Mice; Myocardium; Ovarian Neoplasms; Pregnancy

1985